SCHEMBL23833503

SCHEMBL23833503

N#Cc1c(-c2ccc(O)c(O)c2)cc(-c2ccc(F)cc2)nc1N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IL4 P05112 1/20 1.00
KDM4E B2RXH2 8/20 0.74
TDP1 Q9NUW8 1/20 0.74
ADORA1 P30542 6/20 0.70
ADORA2A P29274 5/20 0.70
HPGD P15428 7/20 0.59
ALDH1A1 P00352 6/20 0.59
MAPT P10636 6/20 0.59
MEN1 O00255 5/20 0.59
KMT2A Q03164 5/20 0.59
SMN1; SMN2 Q16637 4/20 0.59
GAA P10253 3/20 0.59
GLA P06280 2/20 0.59
CASP1 P29466 2/20 0.59
CASP7 P55210 2/20 0.59
HSD17B10 Q99714 2/20 0.59
PSMD14 O00487 1/20 0.59
USP2 O75604 1/20 0.59
TSHR P16473 1/20 0.59
PIM1 P11309 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23833502 1.00 IL4 (1.00) IL4KDM4ETDP1ADORA1ADORA2A
SCHEMBL31695332 0.88 IL4 (0.78) IL4KDM4ETDP1ADORA1ADORA2A
SCHEMBL3371543 0.87 ADORA1 (0.89) IL4KDM4ETDP1ADORA1ADORA2A
SCHEMBL23841221 0.87 IL4 (0.77) IL4KDM4ETDP1ADORA1ADORA2A
SCHEMBL29331857 0.87 IL4 (0.77) IL4KDM4ETDP1ADORA1ADORA2A
SCHEMBL31139632 0.86 ADORA1 (0.78) IL4KDM4ETDP1ADORA1ADORA2A
SCHEMBL31139657 0.86 KDM4E (1.00) IL4KDM4ETDP1ADORA1ADORA2A
SCHEMBL31695349 0.84 IL4 (0.72) IL4KDM4ETDP1ADORA1ADORA2A
SCHEMBL31695325 0.84 IL4 (0.72) IL4KDM4ETDP1ADORA1ADORA2A
SCHEMBL31695312 0.83 ADORA1 (0.72) IL4KDM4ETDP1ADORA1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240391913-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2024-11-28 US disclosed
US-12043621-B2 Small molecule inhibitors of Interleukin-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2024-07-23 US disclosed
US-20210317114-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2021-10-14 US disclosed
WO-2021188871-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2021-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12043621-B2 Small molecule inhibitors of Interleukin-4 IL4, IL2, IL4I1 IL4 1/4885KDM4E 586/4885TDP1 4759/4885
US-20240391913-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 IL4, IL2, IL4I1 IL4 1/4885KDM4E 586/4885TDP1 4759/4885
US-20210317114-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 IL4, IL2, IL4I1 IL4 1/4885KDM4E 586/4885TDP1 4759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.